The LRC-TriCEPS platform identified 2 new receptors for ApoA-1, potentially new drug targets for Diabetes Type 2

November 15, 2024

LRC-TriCEPS identified a completely new mechanism of monocyte activation that might be clinically relevant in Alzheimers’ and inflammation diseases. Feb 2023

February 11, 2023

Identification of a receptor for house dust mite allergens

March 23, 2023

Sensei Biotherapeutics Presents Preclinical Data at the 37th Society for Immunotherapy of Cancer (SITC) Annual Meeting

November 10, 2022

Identification of key extracellular binding proteins

July 25, 2022

Latrophilin-2 is a novel receptor of LRG1

May 13, 2022

TFF3 interacts with LINGO2 to regulate EGFR activation for protection against colitis and gastrointestinal helminths

September 27, 2019

Neuroplastin Modulates Anti-inflammatory Effects of MANF

December 18, 2020

NKG2A/CD94 Is a New Immune Receptor for HLA-G and Distinguishes Amino Acid Differences in the HLA-G Heavy Chain

June 19, 2020

Akkermansia muciniphila secretes a gluc.-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice

April 05, 2021